 | 1090 views, By Natural Field Co., Ltd. Natural Field, a nutraceutical ingredient manufacturer specializing in innovative delivery systems, unveiled NF TriSolve® at CPHI China 2026, showcasing its latest advancement in science-driven nutritional formulation solutions.
|
242 views, By Normopharm Inc What do nine animal studies reveal about lithium ascorbate? Explore new preprints on its safety, absorption, tissue distribution, and dose-related effects.
|
445 views, By Roohid Parast Science & Fitness Blood test tracking treatment response diverges sharply between IL-17/IL-23 inhibitors and older therapies, new 12-month study finds
|
1141 views, By CDI Global CDI Global Iberia has advised the Thiebaut family on the strategic partnership between Cobiosa and Sparkfood, the Sonae group's ingredients platform.
|
909 views, By Blackthorn Publishing As Southern Nevada public systems face mounting pressure, families seeking timely answers after the death of a loved one are often left waiting in uncertainty.
|
655 views, By Roohid Parast Science & Fitness J&J translational scientist and AI-focused MBA candidate says competitive business training and clinical research demand the same analytical instincts.
|
1018 views, By Blackthorn Publishing A growing number of families in Phoenix and across Arizona are seeking independent medical examinations through private autopsy services to find definitive answers following the loss of a loved one.
|
418 views, By ScionxBio The rebrand follows a strategic horizontal split; ScionxBio focuses the xRNA modality exclusively on long-acting therapeutics for cardio-metabolic disease under new CEO Dr. Adi Gilboa-Geffen
|
 | 1787 views, By CorporateAds First Commercial Deployment of FDA-Cleared AI-Guided TMS Navigation System, Expanded FDA Pathway for NRX-101, and Growing Commercial Infrastructure Highlight Accelerating Momentum for NRx Pharmaceuticals (N A S D A Q: NRXP)
|
1456 views, By Grayed AI A practical guide to what FDA reviewers expect from training data, model evaluation, and documentation in an AI SaMD submission.
|
926 views, By ASCL An open Bayesian Causal Atlas now reports, for every disease it covers — including non-fatal conditions — the best-case modelled reduction achievable when all applicable beneficial interventions are combined under a Pearl structural-causal framework.
|
1898 views, By Cryolab New article covers real-world evaporation loss, storage capacity planning, IATA dry shipper compliance, and missed safety hazards in UK fertility labs
|
 | 2882 views, By Black Dog Venture Partners Premier Pitch Event Connects Women Entrepreneurs in Life Sciences with Investors from Across the Country
|
424 views, By PurMa Biologics Oklahoma City biotech company releases step-by-step mycoplasma detection and elimination protocol
|
362 views, By Genix.ai AI-native platform delivers molecular docking, bioinformatics pipeline development, and end-to-end computational biology — at 50–70% lower cost than traditional CROs
|
285 views, By American Conference Institute ACI and the Boardroom partner to empower aspiring women board members
|
 | 1095 views, By CorporateAds Cosmos Health Inc. (N A S D A Q: COSM): 18 Series Nutraceutical Expansion, Record Q1 Results, EIB Financing Initiative, AI-Powered Drug Development, And Strong Long-Term Financial Guidance Position Cosmos Health For Potential Multi-Year Expansion
|
 | 1066 views, By The Society for Scientific Exploration The Society for Scientific Exploration is proud to announce their 44th Annual Conference event will be held June 17–21, 2026, at the Denver Marriott Westminster Hotel in Colorado.
|
359 views, By Michael Aaron Russell Foundation for Aligned Intelligence Truth and Humanity (F.A.I.T.H.) Sets Definitive Industry Benchmark by Codifying Machine-Verifiable Logic for Global Pharmaceutical Manufacturing.
|
 | 1192 views, By CorporateAds Cosmos Health Inc. (N A S D A Q: COSM): Veterinary Expansion, Proprietary Healthcare Brands, AI-Powered Drug Development, Telehealth Growth, and Strong Financial Guidance Position Cosmos Health for Potential Multi-Year Expansion
|
 | 1959 views, By CorporateAds Expanding HOPE Therapeutics Network Positions NRx Pharmaceuticals, Inc. (N A S D A Q: NRXP) $NRXP for Potential Breakout 2026 Growth
|
 | 1808 views, By CorporateAds NRx Pharmaceuticals, Inc.Improved Financial Position, Commercial Ketamine Manufacturing, FDA Progress, and Expanding Neuroplastic Therapy Infrastructure Position $NRXP for a Potential Breakout Phase
|
456 views, By Ameco Research Gene Editing Market is projected to reach USD 28.4 Billion by 2032, growing at 16.5% CAGR driven by CRISPR advancements, rising genetic research, precision medicine demand, and increasing biotechnology investments globally.
|
708 views, By Roohid Parast Science & Fitness Translational scientist pursues MBA with AI concentration, bridging clinical biomarker research and emerging technology
|
1131 views, By Blackthorn Publishing Postmortem Pathology, a forensic pathology firm, is urging communities to recognize private autopsies as a vital component of standard medical best practices.
|
333 views, By Skyquest Technology Drug Discovery Services Market grows with rising pharma R&D, CRO outsourcing, AI-driven research, biologics development, and precision medicine demand.
|
319 views, By Medpharma News Global Animal Biotechnology Market is projected to reach USD 57.9 Billion by 2032 at 8.9% CAGR driven by animal health innovation, genetic engineering, vaccines, cloning technologies, and livestock productivity demand.
|
463 views, By Green Natural Wonders As the world enters an era defined by climate instability, resource competition, artificial intelligence, and the race for next-generation materials, Sahit Muja is advancing a vision that reaches far beyond conventional sustainability, a new industrial...
|
2243 views, By Genosera Inc. Genosera Inc. Exclusively Licenses Seven Novel IP Assets from Nationwide Children's Hospital, Readying for Gene Therapy Clinical Development
|
425 views, By USA Corp./ Advanceer IVS Primarch Michael A. Russell Introduces a New Category of Machine Verifiable Biomedical Reasoning
|
2167 views, By ConformanceX Ltd PRESS RELEASE General Media | Embargoed to May 7, 2026 New platform launches to close the gap between drug approval and patient access London, UK – May 7, 2026 – BrandLaunchX, an AI-powered platform for biotech and pharmaceutical launch...
|